tiprankstipranks
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market

Harmony Biosciences Holdings (HRMY) Income Statement

Compare
243 Followers

Harmony Biosciences Holdings Income Statement

Last quarter (Q3 2024), Harmony Biosciences Holdings's total revenue was $186.04M, an increase of 16.08% from the same quarter last year. In Q3, Harmony Biosciences Holdings's net income was $46.09M. See Harmony Biosciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 582.02M$ 437.86M$ 305.44M$ 159.74M$ 6.00M
Gross Profit
$ 460.79M$ 354.37M$ 249.92M$ 132.00M$ 4.42M
Operating Expenses
$ 268.76M$ 234.19M$ 162.39M$ 115.02M$ 150.32M
Depreciation and Amortization
$ 24.36M$ 23.39M$ 18.84M$ 10.24M$ 3.21M
EBITDA
$ 221.51M$ 143.57M$ 106.37M$ 1.51M$ -142.69M
Operating Income
$ 192.03M$ 120.19M$ 68.70M$ 3.68M$ -145.90M
Other Income/Expenses
$ -18.63M$ -15.50M$ -50.10M$ -53.93M$ -6.07M
Pretax Income
$ 173.40M$ 104.69M$ 37.43M$ -36.94M$ -151.98M
Net Income
$ 128.85M$ 181.47M$ 34.60M$ -51.86M$ -158.05M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 2.17$ 3.07$ 0.60$ -0.91$ -2.48
Diluted EPS
$ 2.13$ 2.97$ 0.58$ -0.91$ -2.48
Weighted Average Shares Outstanding
59.47M 59.17M 57.53M 56.89M 63.68M
Weighted Average Shares Outstanding (Diluted)
60.37M 61.10M 59.21M 56.89M 63.68M
Currency in USD

Harmony Biosciences Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis